{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:22Z","timestamp":1794435922332,"version":"4.9.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Children's Charity","doi-asserted-by":"publisher","award":["VS0122"],"award-info":[{"award-number":["VS0122"]}],"id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T007087\/1"],"award-info":[{"award-number":["MR\/T007087\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S011005\/1"],"award-info":[{"award-number":["MR\/S011005\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V034758\/1"],"award-info":[{"award-number":["MR\/V034758\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000295","name":"Epilepsy Research Institute UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012357","name":"LifeArc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102942","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:21:00Z","timestamp":1777594860000},"page":"102942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["AAV9-mediated targeting of natural antisense transcript as a novel treatment for Dravet syndrome"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-2738","authenticated-orcid":false,"given":"Juan Antinao","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie M.","family":"Chilcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Almacellas","family":"Barbanoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Gurung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valda","family":"Pauzuolyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zak","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kyriacou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"McTague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Helen","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Schorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Lignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon N.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-483X","authenticated-orcid":false,"given":"Rajvinder","family":"Karda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102942_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108741","article-title":"Genetic therapeutic advancements for Dravet Syndrome","volume":"132","author":"Chilcott","year":"2022","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.omtn.2026.102942_bib2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/epi4.12832","article-title":"Dravet syndrome: a systematic literature review of the illness burden","volume":"8","author":"Strzelczyk","year":"2023","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.omtn.2026.102942_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/epi.12652","article-title":"Dravet syndrome\u2014From epileptic encephalopathy to channelopathy","volume":"55","author":"Brunklaus","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.omtn.2026.102942_bib4","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1212\/WNL.0000000000200028","article-title":"Development and Validation of a Prediction Model for Early Diagnosis of SCN1A-Related Epilepsies","volume":"98","author":"Brunklaus","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2026.102942_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2006.00688.x","article-title":"Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings","volume":"47","author":"Wolff","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.omtn.2026.102942_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-328X(00)00289-8","article-title":"Comparative distribution of voltage-gated sodium channel proteins in human brain","volume":"88","author":"Whitaker","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.omtn.2026.102942_bib7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"Yu","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtn.2026.102942_bib8","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1523\/JNEUROSCI.5270-06.2007","article-title":"Nav1.1 Localizes to Axons of Parvalbumin-Positive Inhibitory Interneurons: A Circuit Basis for Epileptic Seizures in Mice Carrying an Scn1a Gene Mutation","volume":"27","author":"Ogiwara","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2026.102942_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/14734220309424","article-title":"Expression and distribution of voltage-gated sodium channels in the cerebellum","volume":"2","author":"Schaller","year":"2003","journal-title":"Cerebellum"},{"key":"10.1016\/j.omtn.2026.102942_bib10","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1002\/j.1460-2075.1989.tb08534.x","article-title":"Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development","volume":"8","author":"Beckh","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.omtn.2026.102942_bib11","doi-asserted-by":"crossref","first-page":"11065","DOI":"10.1523\/JNEUROSCI.2162-07.2007","article-title":"Reduced sodium current in Purkinje neurons from Nav1. 1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy","volume":"27","author":"Kalume","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2026.102942_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.823640","article-title":"Functional investigation of a neuronal microcircuit in the CA1 area of the hippocampus reveals synaptic dysfunction in Dravet syndrome mice","volume":"15","author":"Almog","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtn.2026.102942_bib13","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/dmcn.14990","article-title":"Dysautonomia and functional impairment in rare developmental and epileptic encephalopathies: the other nervous system","volume":"63","author":"Berg","year":"2021","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.omtn.2026.102942_bib14","doi-asserted-by":"crossref","first-page":"e77843","DOI":"10.1371\/journal.pone.0077843","article-title":"Altered Cardiac Electrophysiology and SUDEP in a Model of Dravet Syndrome","volume":"8","author":"Auerbach","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2026.102942_bib15","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI66220","article-title":"Sudden unexpected death in a mouse model of Dravet syndrome","volume":"123","author":"Kalume","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.omtn.2026.102942_bib16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1113\/jphysiol.2014.278259","article-title":"Contribution of sodium channel neuronal isoform Nav1.1 to late sodium current in ventricular myocytes from failing hearts","volume":"593","author":"Mishra","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.omtn.2026.102942_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.01.006","article-title":"Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice","volume":"65","author":"Mistry","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2026.102942_bib18","doi-asserted-by":"crossref","first-page":"14646","DOI":"10.1073\/pnas.1211591109","article-title":"Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome","volume":"109","author":"Cheah","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102942_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/gbb.12099","article-title":"Mapping genetic modifiers of survival in a mouse model of Dravet syndrome","volume":"13","author":"Miller","year":"2014","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.omtn.2026.102942_bib20","article-title":"Developmental instability of CA1 pyramidal cells in Dravet Syndrome","author":"Jones","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2026.102942_bib21","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/epi.14438","article-title":"Heart rate variability in epilepsy: A potential biomarker of sudden unexpected death in epilepsy risk","volume":"59","author":"Myers","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.omtn.2026.102942_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/epi4.12569","article-title":"Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe","volume":"7","author":"Cardenal-Mu\u00f1oz","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.omtn.2026.102942_bib23","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102942_bib24","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41591-022-01866-4","article-title":"Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102942_bib25","doi-asserted-by":"crossref","first-page":"9933","DOI":"10.1128\/JVI.79.15.9933-9944.2005","article-title":"Packaging Capacity of Adeno-Associated Virus Serotypes: Impact of Larger Genomes on Infectivity and Postentry Steps","volume":"79","author":"Grieger","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102942_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn5603","article-title":"Interneuron-specific dual-AAV SCN1A gene replacement corrects epileptic phenotypes in mouse models of Dravet syndrome","volume":"17","author":"Mich","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102942_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159316","article-title":"Viral vector\u2013mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome","volume":"133","author":"Fadila","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.omtn.2026.102942_bib28","doi-asserted-by":"crossref","first-page":"eaaz6100","DOI":"10.1126\/scitranslmed.aaz6100","article-title":"Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome","volume":"12","author":"Han","year":"2020","journal-title":"Science translational medicine"},{"key":"10.1016\/j.omtn.2026.102942_bib29","year":"2025","journal-title":"Internet"},{"key":"10.1016\/j.omtn.2026.102942_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2506295","article-title":"Zorevunersen in Children and Adolescents with Dravet Syndrome","volume":"394","author":"Laux","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102942_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/hum.2022.037","article-title":"Cell-Selective Adeno-Associated Virus-Mediated SCN1A Gene Regulation Therapy Rescues Mortality and Seizure Phenotypes in a Dravet Syndrome Mouse Model and Is Well Tolerated in Nonhuman Primates","volume":"33","author":"Tanenhaus","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102942_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ebiom.2016.05.011","article-title":"Upregulation of Haploinsufficient Gene Expression in the Brain by Targeting a Long Non-coding RNA Improves Seizure Phenotype in a Model of Dravet Syndrome","volume":"9","author":"Hsiao","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2026.102942_bib34","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/nar\/gkl143","article-title":"Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC\/miR-155","volume":"34","author":"Chung","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102942_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.omtn.2018.05.001","article-title":"RNA Polymerase II Activity of Type 3 Pol III Promoters","volume":"12","author":"Gao","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102942_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2006.00688.x","article-title":"Severe Myoclonic Epilepsy of Infants (Dravet Syndrome): Natural History and Neuropsychological Findings","volume":"47","author":"Wolff","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.omtn.2026.102942_bib37","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1096\/fj.14-269092","article-title":"Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates","volume":"29","author":"Mattar","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.omtn.2026.102942_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymthe.2019.08.018","article-title":"dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice","volume":"28","author":"Colasante","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102942_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/hum.2019.225","article-title":"Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome","volume":"31","author":"Niibori","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102942_bib40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.omtn.2021.08.003","article-title":"Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations","volume":"25","author":"Mora-Jimenez","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102942_bib41","doi-asserted-by":"crossref","first-page":"11866","DOI":"10.1073\/pnas.1900437116","article-title":"Why haploinsufficiency persists","volume":"116","author":"Morrill","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102942_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1461","article-title":"Natural antisense transcripts in diseases: From modes of action to targeted therapies","volume":"9","author":"Wanowska","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.omtn.2026.102942_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1051559","article-title":"Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors","volume":"13","author":"Hollidge","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtn.2026.102942_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.omtn.2026.102942_bib45","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s44321-024-00037-x","article-title":"Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor","volume":"16","author":"Xie","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2026.102942_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41467-021-27837-w","article-title":"Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome","volume":"13","author":"Valassina","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102942_bib47","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1073\/pnas.0813330106","article-title":"Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy","volume":"106","author":"Oakley","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102942_bib48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11248-022-00314-w","article-title":"Genetic quality: a complex issue for experimental study reproducibility","volume":"31","author":"Yoshiki","year":"2022","journal-title":"Transgenic Res."},{"key":"10.1016\/j.omtn.2026.102942_bib49","doi-asserted-by":"crossref","first-page":"E7622","DOI":"10.1073\/pnas.1710848114","article-title":"CD146 coordinates brain endothelial cell\u2013pericyte communication for blood\u2013brain barrier development","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102942_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1113\/jphysiol.1995.sp020978","article-title":"Developmental changes in blood-brain barrier potassium permeability in the rat: relation to brain growth","volume":"488","author":"Keep","year":"1995","journal-title":"J. Physiol."},{"key":"10.1016\/j.omtn.2026.102942_bib51","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102942_bib52","doi-asserted-by":"crossref","DOI":"10.1515\/tnsci-2022-0330","article-title":"Brain expression profiles of two SCN1A antisense RNAs in children and adolescents with epilepsy","volume":"15","author":"Schneider","year":"2024","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.omtn.2026.102942_bib53","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102942_bib54","article-title":"Gene Therapy Prevents Hepatic Mitochondrial Dysfunction in Murine Deoxyguanosine Kinase Deficiency","author":"Keshavan","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2026.102942_bib55","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ejn.12126","article-title":"Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo","volume":"37","author":"Kim","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.omtn.2026.102942_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/srep41874","article-title":"Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in mice","volume":"7","author":"Delhove","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102942_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2019.02.029","article-title":"PTZ-induced seizures in mice require a revised Racine scale","volume":"95","author":"Van Erum","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.omtn.2026.102942_bib58","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1096\/fj.11-182311","article-title":"Intravenous administration of AAV2\/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system","volume":"25","author":"Rahim","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2026.102942_bib59","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41598-020-59075-3","article-title":"Generation of light-producing somatic-transgenic mice using adeno-associated virus vectors","volume":"10","author":"Karda","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102942_bib60","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.102942_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.omtn.2026.102942_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1149391","article-title":"Heat-induced seizures, premature mortality, and hyperactivity in a novel Scn1a nonsense model for Dravet syndrome","volume":"17","author":"Mavashov","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtn.2026.102942_bib63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A review and computer program","volume":"11","author":"Dupont","year":"1990","journal-title":"Control. Clin. Trials"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:29:51Z","timestamp":1794432591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126001137"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102942","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.27.615323","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV9-mediated targeting of natural antisense transcript as a novel treatment for Dravet syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102942"}}